Related Experiment Video
Updated: Jun 11, 2025

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.3K
Molecular Interactions between Tau Protein and TIA1: Distinguishing Physiological Condensates from Pathological
Safwa T Kizhakkeduth1, Arshad Abdul Vahid1, Muhammed Shafeek Oliyantakath Hassan1
1School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), Vithura, Thiruvananthapuram 695551, India.
ACS Chemical Neuroscience
|October 7, 2024
Summary
The tau protein
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- The interaction between tau protein and stress granule proteins is crucial for cellular function and disease.
- Alzheimer's disease is linked to tau pathology and stress granule dysregulation.
- The precise molecular mechanisms governing tau's interaction with TIA1 remain largely unknown.
Purpose of the Study:
- To investigate how the structural state of TIA1 (stress granule condensate vs. fibril) influences its interaction with tau protein.
- To elucidate the molecular details of tau-TIA1 association under different TIA1 structural conformations.
Main Methods:
- Utilized three-repeat constructs of tau (K19) and full-length TIA1 (TIA1-FL) condensates.
- Examined tau aggregation kinetics with TIA1 low-complexity domain (TIA1-LCD) fibrils.
- Employed biophysical techniques, including relaxation-based solution NMR spectroscopy.
Main Results:
- Tau protein (K19) showed reduced dynamics and weak interaction within TIA1-FL condensates.
- Significant interaction was observed between K19 and TIA1-LCD fibrils.
- Specific regions (321KCGS324 and 306VQIVYKPVDLSKV317) mediated the K19-TIA1-LCD fibril interaction.
Conclusions:
- The structural state of TIA1 critically dictates its interaction with tau protein.
- Tau's interaction is distinct in physiological TIA1 condensates versus pathological TIA1 fibrils.
- Understanding these differential interactions is key to comprehending tau's role in neurodegenerative diseases.

